Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis
暂无分享,去创建一个
V. Arndt | M. Thong | Zhunzhun Liu | Keyi Yang | D. Doege
[1] Y. Tang,et al. Increased risk of diabetes in cancer survivors: a pooled analysis of 13 population-based cohort studies , 2021, ESMO open.
[2] Weidong Wei,et al. The Influence of Hormone Therapy on secondary diabetes mellitus in Breast Cancer: A Meta-analysis. , 2021, Clinical breast cancer.
[3] Shih-Yi Lin,et al. Risk of diabetes mellitus in patients with prostate cancer receiving injection therapy: A nationwide population‐based propensity score‐matched study , 2021, International journal of clinical practice.
[4] C. Cook,et al. Survival and glycemic control in patients with co-existing squamous cell carcinoma and diabetes mellitus , 2021, Future science OA.
[5] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[6] A. Jemal,et al. Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.
[7] T. George,et al. New onset of type 2 diabetes as a complication after cancer diagnosis: A systematic review , 2020, Cancer medicine.
[8] Yazhou He,et al. Risk of Stroke in Cancer Survivors , 2020, Neurology.
[9] C. Portwine,et al. 42 - The Prevalence of Diabetes Mellitus in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis , 2020 .
[10] S. Bhatia,et al. Chronic Comorbidities Among Survivors of Adolescent and Young Adult Cancer , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] Jason D. Wright,et al. Incidence and Predictors of Diabetes Mellitus after a Diagnosis of Early-Stage Breast Cancer in the Elderly Using Real-World Data , 2020, Breast Cancer Research and Treatment.
[12] A. Blackford,et al. Burden of comorbidities is higher among elderly survivors of oropharyngeal cancer compared with controls , 2020, Cancer.
[13] Ken R. Smith,et al. Long-term diabetes risk among endometrial cancer survivors in a population-based cohort study. , 2019, Gynecologic oncology.
[14] S. Trestman,et al. Components of metabolic syndrome in patients with multiple myeloma and smoldering multiple myeloma , 2019, BMC Cancer.
[15] J. Meyerhardt,et al. Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance) , 2019, JNCI cancer spectrum.
[16] J. Shaw,et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. , 2019, Diabetes research and clinical practice.
[17] M. Salas,et al. A Retrospective Study of Comorbidities and Complications in Elderly Acute Myeloid Leukemia Patients in the United States. , 2019, Clinical lymphoma, myeloma & leukemia.
[18] Shyang-Rong Shih,et al. Increasing risk of diabetes mellitus in postmenopausal women with newly diagnosed primary breast cancer , 2019, Journal of diabetes investigation.
[19] M. McBride,et al. Patterns of comorbidities in women with breast cancer: a Canadian population-based study , 2019, Cancer Causes & Control.
[20] P. Cohen,et al. Diabetes and Metabolic Syndrome in Survivors of Childhood Cancer , 2019, Hormone Research in Paediatrics.
[21] J. Derksen,et al. Monitoring potentially modifiable lifestyle factors in cancer survivors: A narrative review on currently available methodologies and innovations for large-scale surveillance. , 2018, European journal of cancer.
[22] D. Zylla,et al. Impact of diabetes and hyperglycemia on health care utilization, infection risk, and survival in patients with cancer receiving glucocorticoids with chemotherapy. , 2018, Journal of diabetes and its complications.
[23] E. Guallar,et al. Incidence of Diabetes After Cancer Development: A Korean National Cohort Study , 2018, JAMA oncology.
[24] D. Roder,et al. Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study , 2018, Prostate Cancer and Prostatic Diseases.
[25] Melissa Matz,et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.
[26] D. Roder,et al. Comorbidities in Australian women with hormone‐dependent breast cancer: a population‐based analysis , 2018, The Medical journal of Australia.
[27] Ken R. Smith,et al. Aging-Related Disease Risks among Young Thyroid Cancer Survivors , 2017, Cancer Epidemiology, Biomarkers & Prevention.
[28] Ken R. Smith,et al. Endocrine and Metabolic Diseases among Colorectal Cancer Survivors in a Population-Based Cohort. , 2017, Journal of the National Cancer Institute.
[29] P. Nathan,et al. Diabetes Risk in Childhood Cancer Survivors: A Population-Based Study. , 2018, Canadian journal of diabetes.
[30] S. Buys,et al. Do cancer survivors develop healthier lifestyle behaviors than the cancer-free population in the PLCO study? , 2017, Journal of Cancer Survivorship.
[31] J. Goldman,et al. Hyperglycemia Associated With Targeted Oncologic Treatment: Mechanisms and Management. , 2016, The oncologist.
[32] L. Holmberg,et al. Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer , 2016, International journal of cancer.
[33] C. Teng,et al. Outcome and late effects among acute myeloid leukemia survivors: a nationwide population-based study , 2016, Supportive Care in Cancer.
[34] Jelle J Goeman,et al. Plea for routinely presenting prediction intervals in meta-analysis , 2016, BMJ Open.
[35] K. Hirshfield,et al. Hormonal therapy for breast cancer and diabetes incidence among postmenopausal women. , 2016, Annals of epidemiology.
[36] P. Austin,et al. Incidence of Diabetes in Colorectal Cancer Survivors. , 2016, Journal of the National Cancer Institute.
[37] Ken R. Smith,et al. Long-term health effects among testicular cancer survivors , 2016, Journal of Cancer Survivorship.
[38] M. Kelsh,et al. Racial and Ethnic Variability in the Prevalence and Incidence of Comorbidities Associated with Gastric Cancer in the United States , 2016, Journal of Gastrointestinal Cancer.
[39] C. Chao,et al. Long-term Health Outcomes in Survivors of Childhood Cancer Diagnosed Between 1990 and 2000 in a Large US Integrated Health Care System , 2016, Journal of pediatric hematology/oncology.
[40] Lin Zhao,et al. Androgen deprivation therapy is associated with diabetes: Evidence from meta‐analysis , 2016, Journal of diabetes investigation.
[41] P. Porporato. Understanding cachexia as a cancer metabolism syndrome , 2016, Oncogenesis.
[42] Min Yu,et al. Depression and Risk for Diabetes: A Meta-Analysis. , 2015, Canadian journal of diabetes.
[43] Sun Shengrong,et al. Clinical pathological characteristics of breast cancer patients with secondary diabetes after systemic therapy: a retrospective multicenter study , 2015, Tumor Biology.
[44] E. D. de Vries,et al. Cancer-drug induced insulin resistance: innocent bystander or unusual suspect. , 2015, Cancer treatment reviews.
[45] H. Sørensen,et al. Relative mortality rates from incident chronic diseases among breast cancer survivors--a 14 year follow-up of five-year survivors diagnosed in Denmark between 1994 and 2007. , 2015, European journal of cancer.
[46] Kevin A. Henry,et al. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State , 2015, Journal of the National Cancer Institute.
[47] F Levi,et al. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[48] J. Ioannidis,et al. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies , 2015, BMJ : British Medical Journal.
[49] C. Kao,et al. Association of tamoxifen use and increased diabetes among Asian women diagnosed with breast cancer , 2014, British Journal of Cancer.
[50] T. Lash,et al. Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study , 2014, Breast Cancer Research and Treatment.
[51] C. O’Malley,et al. Prevalence and incidence of comorbidities in elderly women with ovarian cancer. , 2013, Gynecologic oncology.
[52] Geoff M. Anderson,et al. Incidence of diabetes among postmenopausal breast cancer survivors , 2013, Diabetologia.
[53] M. Schlumberger,et al. Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study. , 2012, The Lancet. Oncology.
[54] D. Glass,et al. Cancer cachexia: mediators, signaling, and metabolic pathways. , 2012, Cell metabolism.
[55] R. Herings,et al. Occurrence of Comorbidities before and after Soft Tissue Sarcoma Diagnosis , 2012, Sarcoma.
[56] F. Granath,et al. Evaluation of prevalent and incident ovarian cancer co-morbidity , 2012, British Journal of Cancer.
[57] A. Shukla,et al. Comorbidities and Concomitant Medication Use in Men with Prostate Cancer or High Levels of PSA Compared to Matched Controls: A GPRD Analysis , 2012, Journal of cancer epidemiology.
[58] R. Herings,et al. Prevalence and incidence of acute and chronic comorbidity in patients with squamous cell carcinoma of the head and neck , 2012, Head & neck.
[59] H. Seo,et al. Metabolic syndrome in adult cancer survivors: a meta-analysis. , 2012, Diabetes research and clinical practice.
[60] D. Forman,et al. Long-term health outcomes in a British cohort of breast, colorectal and prostate cancer survivors: a database study , 2011, British Journal of Cancer.
[61] C. O’Malley,et al. An observational study of the prevalence and incidence of comorbid conditions in older women with breast cancer , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.
[62] J. Stanford,et al. Diabetes mellitus and health‐related quality of life in prostate cancer: 5‐year results from the Prostate Cancer Outcomes Study , 2011, BJU international.
[63] N. Keating,et al. Gonadotropin-Releasing Hormone Agonists and the Risks of Type 2 Diabetes and Cardiovascular Disease in Men with Prostate Cancer , 2011, Drugs.
[64] Richard D Riley,et al. Interpretation of random effects meta-analyses , 2011, BMJ : British Medical Journal.
[65] J. Danesh,et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies , 2010, The Lancet.
[66] D. Harlan,et al. Diabetes and Cancer , 2010, Diabetes Care.
[67] Edward Giovannucci,et al. Diabetes and Cancer , 2010, Diabetes Care.
[68] G. Hotamisligil,et al. Mechanisms of TNF-alpha-induced insulin resistance. , 2009 .
[69] Mika Kivimäki,et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study , 2009, The Lancet.
[70] Gerta Rücker,et al. Bmc Medical Research Methodology Open Access Undue Reliance on I 2 in Assessing Heterogeneity May Mislead , 2022 .
[71] S. Basaria. Androgen deprivation therapy, insulin resistance, and cardiovascular mortality: an inconvenient truth. , 2008, Journal of andrology.
[72] M. Sydes,et al. Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.
[73] N. Aziz. Cancer survivorship research: State of knowledge, challenges and opportunities , 2007, Acta oncologica.
[74] D. Elahi,et al. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. , 2005, The Journal of clinical endocrinology and metabolism.
[75] A. Munshi,et al. Weight Loss During Radiotherapy for Head and Neck Malignancies: What Factors Impact It? , 2003, Nutrition and cancer.
[76] R. Schots,et al. Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation , 2003, Leukemia.
[77] Z. Bloomgarden,et al. Inflammation and insulin resistance. , 2003, Diabetes care.
[78] T. Okamura,et al. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease , 2001, Bone Marrow Transplantation.
[79] L. Robison,et al. Changes in body mass index and prevalence of overweight in survivors of childhood acute lymphoblastic leukemia: role of cranial irradiation. , 2000, Medical and pediatric oncology.
[80] G. Smith,et al. Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.
[81] C. Begg,et al. Operating characteristics of a rank correlation test for publication bias. , 1994, Biometrics.
[82] R. Bergman,et al. Insulin action and metabolism in patients with head and neck cancer , 1991, Cancer.
[83] P. Tugwell,et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-Analyses , 2014 .
[84] J. Sundquist,et al. Risk of coronary heart disease in patients with cancer: a nationwide follow-up study from Sweden. , 2012, European journal of cancer.
[85] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.
[86] M. Extermann,et al. Interaction between comorbidity and cancer. , 2007, Cancer control : journal of the Moffitt Cancer Center.